The abstract is read at the publisher; the summary is JClub's.
Brain tumors including glioblastoma, H3 K27-altered diffuse midline glioma, H3 G34-mutant diffuse hemispheric glioma, IDH-mutant glioma, and ependymoma reuse developmental programs and can gain plasticity beyond normal counterparts.
- Why it matters: Tumor biology is often framed as disorganized, but developmental timing, lineage organization, and circuit interactions may better explain how malignant cells persist and resist therapy across ages.
- What they did: The review synthesizes evidence from single-cell, spatial, lineage-tracing, and organoid studies, plus cancer neuroscience work linking neuronal activity, synaptic input, and neuromodulatory signaling to tumor proliferation, migration, epigenetic state, and therapeutic response.
- The result: Viewing these cancers as aberrant developmental systems suggests that mapping developmental dependencies and circuit vulnerabilities of progenitor-like states could enable more precise therapies that target tumor biology while preserving essential brain function.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.